Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens
Daniela Visaggio, Emanuela Frangipani, Sarah Hijazi, Mattia Pirolo, Livia Leoni, Giordano Rampioni, Francesco Imperi, Lawrence R. Bernstein, Raffaella Sorrentino, Francesca Ungaro, Paolo Visca
Abstract
were more sensitive to GaPPIX. The results of this study support the development of Ga(III)-based therapy as a broad-spectrum strategy to treat CF lung infections.
Topics & Concepts
MicrobiologyStenotrophomonas maltophiliaCystic fibrosisHaemophilus influenzaePseudomonas aeruginosaBurkholderiaStreptococcus pneumoniaeAchromobacter xylosoxidansMoraxella catarrhalisAntimicrobialNontuberculous mycobacteriaAntibioticsSiderophoreBiologyBacteriaMycobacteriumGeneticsCystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingInfections and bacterial resistance